GlassScriptPhysician profile
Alexandra Goldman
NPI 1487717823
$1,661.95
in general payments reported to CMS, 2019-2025
23 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $33.79 · 2021: $143 · 2022: $212 · 2023: $641 · 2024: $166 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810 · Education: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.29 |
| Education | $327.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.29 | 2021-2023 | |
| Astellas Pharma US INC | $306.07 | 2023-2025 | Veozah |
| Pfizer INC. | $146.46 | 2019-2023 | |
| Hologic Sales and Service, LLC | $129.93 | 2022-2025 | Acessa Provu System |
| Mayne Pharma Commercial LLC | $110.43 | 2021-2024 | |
| Biogen, INC. | $87.55 | 2024-2025 | Vumerity, Zurzuvae |
| Evofem Biosciences, INC. | $71.49 | 2021-2022 | |
| Millicent US INC | $68.82 | 2023-2024 | Femring, Intrarosa |
| Sumitomo Pharma America, INC. | $65.96 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $49.46 | 2019-2020 | |
| Minerva Surgical, INC | $49.30 | 2022-2025 | |
| Sage Therapeutics, LLC | $34.48 | 2025 | |
| Coopersurgical, INC. | $32.61 | 2019 | |
| Merck Sharp & Dohme LLC | $32.27 | 2019-2021 | |
| Exeltis, USA INC. | $31.82 | 2023-2025 | Slynd |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $25.31 | 2021-2023 | Balcoltra |
| Dexcom, INC. | $17.43 | 2025 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $17.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.04 | 2019 | |
| Currax Pharmaceuticals LLC | $13.71 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $12.22 | 2021 | |
| Allergan, INC. | $11.07 | 2019 | |
| Organon LLC | $4.13 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Goldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.